High treatment adherence, satisfaction, motivation, and health-related quality of life with fingolimod in patients with relapsing-remitting multiple sclerosis – results from a 24-month, multicenter, open-label Danish study

References

• National Multiple Sclerosis SocietyMultiple Sclerosis FAQs Available from: http://www.nationalmssociety.org/What-is-MS/MS-FAQ-sAccessed March 18, 2016
   Google Scholar
• LemusHNWarringtonAERodriguezMMultiple sclerosis: mechanisms of disease and strategies for myelin and axonal repairNeurol Clin20183611129157392
   PubMed Web of Science ®Google Scholar
• WingerchukDMCarterJLMultiple sclerosis: current and emerging disease-modifying therapies and treatment strategiesMayo Clin Proc20148922524024485135
   PubMed Web of Science ®Google Scholar
• KargiotisOPaschaliAMessinisLQuality of life in multiple sclerosis: effects of current treatment optionsInt Rev Psych2010226782
   Google Scholar
• WingerchukDMWeinshenkerBGDisease modifying therapies for relapsing multiple sclerosisBMJ2016354i351827549763
   PubMed Web of Science ®Google Scholar
• SabatéEAdherence to Long-Term Therapies: Evidence for ActionGenevaWorld Health Organization2003 Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en/index.htmlAccessed December 7, 2017
   Google Scholar
• PattiFOptimizing the benefit of multiple sclerosis therapy: the importance of treatment adherencePatient Prefer Adherence201041920165593
   PubMed Web of Science ®Google Scholar
• MunsellMFreanMMenzinJPhillipsALAn evaluation of adherence in patients with multiple sclerosis newly initiating treatment with a self-injectable or an oral disease-modifying drugPatient Prefer Adherence201711556228115831
   PubMed Web of Science ®Google Scholar
• HigueraLCarlinCSAndersonSAdherence to disease-modifying therapies for multiple sclerosisJ Manag Care Spec Pharm2016221394140127882830
   PubMed Web of Science ®Google Scholar
• SteinbergSCFarisRJChangCFImpact of adherence to interferons in the treatment of multiple sclerosis – a non-experimental, retrospective, cohort studyClin Drug Investig20103089100
   PubMed Web of Science ®Google Scholar
• TanHCaiQAgarwalSStephensonJJKamatSImpact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosisAdv Ther201128516121153000
   PubMed Web of Science ®Google Scholar
• European Medicines AgencySummary of Product Characteristic for Fingolimod Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002202/human_med_001433.jsp&mid=WC0b01ac058001d125Accessed February 1, 2018
   Google Scholar
• ZiemssenTMedinJCoutoCAMMitchellCRMultiple sclerosis in the real world: a systematic review of fingolimod as a case studyAutoimmun Rev20171635537628212923
   PubMed Web of Science ®Google Scholar
• MoyersTBMartinTManuelJKAssessing competence in the use of motivational interviewingJ Subst Abuse Treat200528192615723728
   PubMed Web of Science ®Google Scholar
• RollnickSMillerWRWhat is motivational interviewing?Behav Cogn Psychother199523325334
   Google Scholar
• RubakSSandbækALauritzenTChristensenBMotivational interviewing: a systematic review and meta-analysisBr J Gen Pract20055530531215826439
   PubMed Web of Science ®Google Scholar
• PolmanCHReingoldSCEdanGDiagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”Ann Neurol20055884084616283615
   PubMed Web of Science ®Google Scholar
• LublinFDReingoldSCDefining the clinical course of multiple sclerosis: results of an international surveyNeurology1996469079118780061
   PubMed Web of Science ®Google Scholar
• BharmalMPayneKAtkinsonMJValidation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medicationsHealth Qual Life Outcomes20092736
   Web of Science ®Google Scholar
• ZhangZGersteinDRFriedmannPDPatient satisfaction and sustained outcomes of drug abuse treatmentJ Health Psychol20081338840018420772
   PubMed Web of Science ®Google Scholar
• MartinLRWilliamsSLHaskardKBDimatteoMRThe challenge of patient adherenceTher Clin Risk Manag2005118919918360559
   PubMedGoogle Scholar
• DiMatteoMRGiordaniPJLepperHSCroghanTWPatient adherence and medical treatment outcomes: a meta-analysisMed Care20024079481112218770
   PubMed Web of Science ®Google Scholar
• WilliamsGCDeciELRyanRMImproving patients’ health through supporting the autonomy of patients and providersDelciELRyanMHandbook of Self-Determination ResearchRochester, NYUniversity of Rochester Press2002233254
   Google Scholar
• WilliamsGCDeciELRyanRMBuilding health-care partnerships by supporting autonomy: promoting maintained behavior change and positive health outcomesSuchmanALHinton-WalkerPBotelhoRPartnerships in Healthcare: Transforming Relational ProcessRochester, NYUniversity of Rochester Press19986787
   Google Scholar
• LevesqueCSWilliamsGCElliotDValidating the theoretical structure of the Treatment Self-Regulation Questionnaire (TSRQ) across three different health behaviorsHealth Educ Res20072269170217138613
   PubMed Web of Science ®Google Scholar
• GremigniPSommarugaMPeltenburgMValidation of the Health Care Communication Questionnaire (HCCQ) to measure outpatients’ experience of communication with hospital staffPat Educ Counsl2008715764
   PubMed Web of Science ®Google Scholar
• BowlingAMeasuring Disease: A Review of Disease Specific Quality of Life InstrumentsBuckingham, PhiladelphiaPhiladelphia Open University Press1995119
   Google Scholar
• JohannessonMEconomic evaluation of drugs and its potential uses in policy makingPharmacoeconomics1995819019810172485
   PubMed Web of Science ®Google Scholar
• WareJEKosinskiMKellerSDA 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validityMed Care1996342202338628042
   PubMed Web of Science ®Google Scholar
• JanzenWTurpinKVLWarrenSAMarrieRAWarrenKGChange in the Health-Related Quality of Life of multiple sclerosis patients over 5 yearsInt J MS Care201315465324453762
   PubMedGoogle Scholar
• GolinCEEarpJTienHCStewartPPorterCHowieLA 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ARTJ Acquir Immune Defic Syndr200642425116763491
   PubMed Web of Science ®Google Scholar
• OgedegbeGChaplinWSchoenthalerAA practice-based trial of motivational interviewing and adherence in hypertensive African AmericansAm J Hypertens2008211137114318654123
   PubMed Web of Science ®Google Scholar
• JohnsonKMZhouHLinFKoJJHerreraVReal-world adherence and persistence to oral disease-modifying therapies in multiple sclerosis patients over 1 yearJ Manag Care Spec Pharm20172384485228737986
   PubMedGoogle Scholar
• BergvallNPetrillaAAKarkareSUPersistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysisJ Med Econ20141769670725019581
   PubMedGoogle Scholar
• WilliamsMJJohnsonKTrenzHMAdherence, persistence, and discontinuation among Hispanic and African American patients with multiple sclerosis treated with fingolimod or glatiramer acetateCurr Med Res Opin201834110711528857632
   PubMed Web of Science ®Google Scholar
• KapposLRadueEWO’ConnorPA placebo-controlled trial of oral fingolimod in relapsing multiple sclerosisN Engl J Med201036238740120089952
   PubMed Web of Science ®Google Scholar
• CalabresiPARadueEWGoodinDSafety and efficacy of fingolimod in patients with relapsing remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trialLancet Neurol20141354555624685276
   PubMed Web of Science ®Google Scholar
• FoxEEdwardsKBurchGOutcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicentre, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosisMult Scler Relat Dis20143607619
   PubMed Web of Science ®Google Scholar
• CaonCSaundersCSmrtkaJBaxterNShoemakerJInjectable disease-modifying therapy for relapsing-remitting multiple sclerosis: a review of adherence dataJ Neuro Nurse2010S4259
   Google Scholar